TMDIF vs. PROF, ELMD, SKIN, INFU, BSGM, STIM, KRMD, AVR, SGHT, and STSS
Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Profound Medical (PROF), Electromed (ELMD), Beauty Health (SKIN), InfuSystem (INFU), Biosig Technologies (BSGM), Neuronetics (STIM), KORU Medical Systems (KRMD), Anteris Technologies Global (AVR), Sight Sciences (SGHT), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.
Titan Medical vs. Its Competitors
Titan Medical (NASDAQ:TMDIF) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.
Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500.
Profound Medical has a consensus price target of $11.00, suggesting a potential upside of 90.97%. Given Profound Medical's stronger consensus rating and higher probable upside, analysts plainly believe Profound Medical is more favorable than Titan Medical.
In the previous week, Profound Medical had 6 more articles in the media than Titan Medical. MarketBeat recorded 6 mentions for Profound Medical and 0 mentions for Titan Medical. Profound Medical's average media sentiment score of 0.62 beat Titan Medical's score of 0.00 indicating that Profound Medical is being referred to more favorably in the news media.
Titan Medical has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
0.0% of Titan Medical shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Titan Medical has a net margin of 0.00% compared to Profound Medical's net margin of -343.97%. Titan Medical's return on equity of -82.31% beat Profound Medical's return on equity.
Summary
Titan Medical and Profound Medical tied by winning 8 of the 16 factors compared between the two stocks.
Get Titan Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TMDIF vs. The Competition
Titan Medical Competitors List
Related Companies and Tools
This page (NASDAQ:TMDIF) was last updated on 10/15/2025 by MarketBeat.com Staff
